Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies
By: Alessandro Tuzi, Davide Lombardi, Diana Crivellari, Loredana Militello, Tiziana Perin, Manuela La Grassa, Samuele Massarut and Andrea Veronesi
Open Access
|Feb 2013Language: English
Page range: 57 - 62
Published on: Feb 1, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2013 Alessandro Tuzi, Davide Lombardi, Diana Crivellari, Loredana Militello, Tiziana Perin, Manuela La Grassa, Samuele Massarut, Andrea Veronesi, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.